An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
Nationwide Children's Hospital, Columbus, Ohio, United States
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine, Seoul, Korea, Republic of
Department of Anesthesiology Koege Hospital, Koege, Denmark
Assiut Univeristy Hospital, Assiut, Egypt
Hallym University Sacred Heart Hospital, Anyang-si, Dongan-gu, Korea, Republic of
Maimonides Medical Center, Brooklyn, New York, United States
Regina Qu'Appelle Health Region, Regina, Saskatchewan, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.